CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale EVP and CCO sold 1,501 shares at $49.21 ($73,864)
- 4 Open-market sale CEO sold 6,770 shares at $49.21 ($333,152)
- 4 Open-market sale EVP and CFO sold 11,050 shares at an average $50.59 ($559,034)
- 4 Open-market sale President sold 4,308 shares at $49.21 ($211,997)
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale President sold 18,949 shares at $50.07 ($948,729)
- 4 Open-market sale President sold 154,019 shares at an average $50.11 ($7,717,356)
- 4 Open-market buy Director bought 1,050,000 shares at an average $32.05 ($33,652,026)
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 22 of 70 · 1,382 filings